Show simple item record

dc.contributor.authorHinkle, Wyatt A.
dc.contributor.authorHinz, Trista K.
dc.contributor.authorGurulé, Natalia J.
dc.contributor.authorHeasley, Lynn E.
dc.date2019
dc.date.accessioned2023-11-30T02:22:53Z
dc.date.available2023-11-30T02:22:53Z
dc.identifier.urihttps://hdl.handle.net/11124/178590
dc.identifier.urihttps://doi.org/10.25676/11124/178590
dc.description.abstractThis study aims to examine the ability of Eribulin, a non-taxane microtubule inhibitor, to induce a cytokine immune response similar to that of targeted TKI's in lung cancer cell lines, and furthermore to characterize the cytokine response to general growth arrest therapies compared to specific targeted protein kinase inhibitors such as TKI's.
dc.format.mediumarticles
dc.languageEnglish
dc.language.isoeng
dc.publisherColorado School of Mines. Arthur Lakes Library
dc.relation.ispartofReuleaux 2019
dc.rightsCreative Commons CC-BY License or the Creative Commons CC-BY-NC License.
dc.sourceContained in: Reuleaux undergraduate research journal, volume 1, issue 1, https://hdl.handle.net/11124/173054
dc.titleEvaluating eribulin's ability to produce a cytokine immune response in lung cancer
dc.typeText
dc.publisher.originalColorado School of Mines. Reuleaux Undergraduate Research Journal


Files in this item

Thumbnail
Name:
Reuleaux2019_Hinkle-Hinz-Gurul ...
Size:
1.598Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record